SRTS
Sensus Healthcare Inc

1,171
Mkt Cap
$63.38M
Volume
9,223.00
52W High
$5.92
52W Low
$3.03
PE Ratio
-8.14
SRTS Fundamentals
Price
$3.88
Prev Close
$3.85
Open
$3.81
50D MA
$4.53
Beta
0.96
Avg. Volume
99,789.15
EPS (Annual)
-$0.4728
P/B
1.32
Rev/Employee
$458,033.33
$43.37
Loading...
Loading...
News
all
press releases
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners
Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·21d ago
News Placeholder
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·29d ago
News Placeholder
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell
Wall Street Zen lowered shares of Sensus Healthcare from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Sensus Healthcare Q4 Earnings Call Highlights
Sensus Healthcare (NASDAQ:SRTS) used its fourth-quarter and full-year 2025 earnings call to emphasize a major regulatory and reimbursement milestone that management believes reshapes the company's...
MarketBeat·1mo ago
News Placeholder
Sensus Healthcare SRTS Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·1mo ago
News Placeholder
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS
Sensus Healthcare (NASDAQ:SRTS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.09) by...
MarketBeat·1mo ago
News Placeholder
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...
Business Wire·1mo ago
News Placeholder
Preview: Sensus Healthcare's Earnings
read more...
Benzinga·1mo ago
News Placeholder
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Hold" from Brokerages
Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has been given an average recommendation of "Hold" by the five brokerages that are covering the company, MarketBeat Ratings reports. One...
MarketBeat·1mo ago
<
1
2
...
>

Latest SRTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.